Kevin Ronald Sayer
Net Worth

Last updated:

What is Kevin Ronald Sayer net worth?

The estimated net worth of Mr. Kevin Ronald Sayer is at least $260,016,776 as of 8 Apr 2024. He owns shares worth $22,995,333 as insider, has earned $202,831,443 from insider trading and has received compensation worth at least $34,190,000 in DexCom, Inc..

What is the salary of Kevin Ronald Sayer?

Mr. Kevin Ronald Sayer salary is $2,630,000 per year as Executive Chairman, Chief Executive Officer & Pres in DexCom, Inc..

How old is Kevin Ronald Sayer?

Mr. Kevin Ronald Sayer is 67 years old, born in 1958.

What stocks does Kevin Ronald Sayer currently own?

As insider, Mr. Kevin Ronald Sayer owns shares in one company:

Company Title Shares Price per share Total value
DexCom, Inc. (DXCM) Executive Chairman, Chief Executive Officer & Pres 283,893 $81 $22,995,333

What does DexCom, Inc. do?

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

DXCM logo
DXCM
DexCom, Inc.
$81

Kevin Ronald Sayer insider trading

DexCom, Inc.

Mr. Kevin Ronald Sayer has made 108 insider trades between 2012-2024, according to the Form 4 filled with the SEC. Most recently he sold 22,361 units of DXCM stock worth $3,101,650 on 8 Apr 2024.

The largest trade he's ever made was exercising 47,693 units of DXCM stock on 30 Jan 2023. As of 8 Apr 2024 he still owns at least 283,893 units of DXCM stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 22,361 $138.71 $3,101,650
Sale
Common Stock 27,272 $137.96 $3,762,500
Sale
Common Stock 29,675 $134.41 $3,988,646
Sale
Common Stock 12,470 $131.47 $1,639,431
Sale
Common Stock 2,939 $134.07 $394,023
Sale
Common Stock 20,930 $133.55 $2,795,139
Sale
Common Stock 14,993 $132.43 $1,985,568
Sale
Common Stock 37,325 $123.64 $4,614,676
Sale
Common Stock 3,599 $115.7 $416,390
Sale
Common Stock 5,995 $113.83 $682,423
Sale
Common Stock 11,218 $114.39 $1,283,261
Sale
Common Stock 7,261 $110.41 $801,702
Sale
Common Stock 31,203 $109.83 $3,426,901
Sale
Common Stock 9,151 $106.65 $975,972
Sale
Common Stock 47,693 $106.06 $5,058,129
Sale
Common Stock 45,607 $105.75 $4,822,895
Sale
Common Stock 100 $414.99 $41,499
Sale
Common Stock 445 $405.84 $180,599
Sale
Common Stock 405 $407 $164,835
Sale
Common Stock 150 $407.6 $61,140
Sale
Common Stock 400 $408.89 $163,556
Sale
Common Stock 445 $410 $182,450
Sale
Common Stock 405 $411.25 $166,556
Sale
Common Stock 450 $412.27 $185,522
Sale
Common Stock 150 $416.42 $62,463
Sale
Common Stock 50 $413.51 $20,676
Sale
Common Stock 3,000 $418.04 $1,254,120
Sale
Common Stock 22,674 $436.94 $9,907,064
Sale
Common Stock 3,000 $536.15 $1,608,459
Sale
Common Stock 3,000 $648.5 $1,945,488
Sale
Common Stock 6,000 $550.39 $3,302,316
Sale
Common Stock 6,000 $540.28 $3,241,650
Sale
Common Stock 5,535 $380.53 $2,106,228
Sale
Common Stock 5,535 $380.53 $2,106,228
Sale
Common Stock 5,535 N/A N/A
Sale
Common Stock 5,535 $380.53 $2,106,228
Sale
Common Stock 6,221 $366.64 $2,280,886
Sale
Common Stock 6,221 $366.64 $2,280,886
Sale
Common Stock 14,044 $362.92 $5,096,806
Sale
Common Stock 3,857 $360.86 $1,391,837
Sale
Common Stock 3,857 $153.64 $592,605
Sale
Common Stock 3,857 $360.86 $1,391,837
Sale
Common Stock 12,468 $376.92 $4,699,488
Sale
Common Stock 12,468 $376.92 $4,699,488
Sale
Common Stock 12,468 $376.92 $4,699,488
Sale
Common Stock 7,073 $355.05 $2,511,262
Sale
Common Stock 7,073 $355.05 $2,511,262
Sale
Common Stock 39,949 $181.06 $7,233,166
Sale
Common Stock 39,949 $360.9 $14,417,554
Sale
Common Stock 13,233 $322.21 $4,263,765
Sale
Common Stock 4,379 N/A N/A
Sale
Common Stock 1,260 N/A N/A
Sale
Common Stock 13,830 $343.75 $4,754,118
Sale
Common Stock 9,965 $398.3 $3,969,079
Sale
Common Stock 6,000 $420.95 $2,525,670
Sale
Common Stock 6,000 $377.63 $2,265,786
Sale
Common Stock 6,000 $344.34 $2,066,010
Sale
Common Stock 6,000 $265.59 $1,593,534
Sale
Common Stock 20,374 $253.93 $5,173,590
Sale
Common Stock 120 $273.05 $32,766
Sale
Common Stock 4,444 $270.29 $1,201,178
Sale
Common Stock 6,000 $268.56 $1,611,354
Sale
Common Stock 6,000 $242.56 $1,455,384
Sale
Common Stock 6,000 $229.4 $1,376,382
Sale
Common Stock 10,000 $220.76 $2,207,570
Sale
Common Stock 10,000 $157.58 $1,575,780
Sale
Common Stock 10,000 $149.51 $1,495,050
Sale
Common Stock 14,322 $147.79 $2,116,634
Sale
Common Stock 10,000 $170.21 $1,702,080
Sale
Common Stock 10,000 $155.63 $1,556,250
Sale
Common Stock 6,000 $145.87 $875,244
Sale
Common Stock 6,000 $131.45 $788,670
Sale
Common Stock 6,000 $116.32 $697,890
Sale
Common Stock 6,000 $118.32 $709,914
Sale
Common Stock 26,566 $142.79 $3,793,412
Sale
Common Stock 6,000 $143.11 $858,630
Sale
Common Stock 6,000 $149.2 $895,170
Sale
Common Stock 6,000 $141.15 $846,882
Sale
Common Stock 11,162 $121.91 $1,360,715
Option
Non-Qualified Stock Option (right to buy) 11,162 $4.58 $51,122
Option
Common Stock 11,162 $4.58 $51,122
Sale
Common Stock 11,161 $145.73 $1,626,515
Option
Common Stock 11,161 $4.58 $51,117
Option
Non-Qualified Stock Option (right to buy) 11,161 $4.58 $51,117
Option
Non-Qualified Stock Option (right to buy) 11,161 $4.58 $51,117
Option
Common Stock 11,161 $4.58 $51,117
Sale
Common Stock 11,161 $124.88 $1,393,819
Option
Common Stock 11,161 $4.58 $51,117
Option
Non-Qualified Stock Option (right to buy) 11,161 $4.58 $51,117
Sale
Common Stock 25,495 $143.44 $3,657,079
Option
Non-Qualified Stock Option (right to buy) 11,161 $4.58 $51,117
Sale
Common Stock 11,161 $123.43 $1,377,613
Option
Common Stock 11,161 $4.58 $51,117
Sale
Common Stock 14,219 $99.86 $1,419,909
Option
Non-Qualified Stock Option (right to buy) 31,464 $7.63 $240,070
Sale
Common Stock 17,245 $84.37 $1,454,995
Option
Common Stock 31,464 $7.63 $240,070
Sale
Common Stock 6,000 $58.85 $353,094
Sale
Common Stock 12,000 $55 $660,000
Sale
Common Stock 6,000 $69.34 $416,046
Sale
Common Stock 6,000 $69.77 $418,638
Sale
Common Stock 6,000 $71.86 $431,172
Sale
Common Stock 6,000 $69.07 $414,414
Option
Common Stock 3,649 $8.79 $32,075
Option
Non-Qualified Stock Option (right to buy) 3,649 $8.79 $32,075
Sale
Common Stock 8,649 $38.59 $333,748
Sale
Common Stock 10,000 $8.79 $87,900
Option
Common Stock 10,000 $8.79 $87,900
Option
Non-Qualified Stock Option (right to buy) 10,000 $8.79 $87,900
Option
Non-Qualified Stock Option (right to buy) 10,000 $8.79 $87,900
Option
Common Stock 10,000 $8.79 $87,900
Sale
Common Stock 10,000 $8.79 $87,900
Option
Non-Qualified Stock Option (right to buy) 10,000 $8.79 $87,900
Option
Common Stock 10,000 $8.79 $87,900
Sale
Common Stock 10,000 $8.79 $87,900
Option
Common Stock 10,000 $8.79 $87,900
Sale
Common Stock 10,000 $8.79 $87,900
Option
Non-Qualified Stock Option (right to buy) 10,000 $8.79 $87,900
Sale
Common Stock 7,000 $81.87 $573,104
Sale
Common Stock 7,000 $91.79 $642,530
Sale
Common Stock 7,000 $90.78 $635,474
Sale
Common Stock 20,000 $8.79 $175,800
Option
Non-Qualified Stock Option (right to buy) 20,000 $8.79 $175,800
Option
Common Stock 20,000 $8.79 $175,800
Sale
Common Stock 7,000 $79.92 $559,454
Sale
Common Stock 35,000 $75 $2,625,000
Sale
Common Stock 7,000 $75 $525,000
Sale
Common Stock 35,000 $97.42 $3,409,525
Sale
Common Stock 25,000 $68.01 $1,700,325
Sale
Common Stock 10,000 $53.97 $539,700
Sale
Common Stock 20,000 $43.83 $876,500
Sale
Common Stock 12,077 $10.68 $128,934

DexCom key executives

DexCom, Inc. executives and other stock owners filed with the SEC: